Zobrazeno 1 - 10
of 600
pro vyhledávání: '"NAOKI HASHIMOTO"'
Autor:
Takashi Uchino, Hisashi Akiyama, Ryo Okubo, Izumi Wada, Akiko Aoki, Mariko Nohara, Hiroki Okano, Ryotaro Kubota, Yuji Yamada, Atsuhito Toyomaki, Naoki Hashimoto, Satoru Ikezawa, Takahiro Nemoto
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Intervention for social cognition could be key to improving social functioning in patients with schizophrenia. A first step towards its clinical implementation involves interviewing patients about their subjective difficulties with social co
Externí odkaz:
https://doaj.org/article/2aa36027d44a4b33a961290fcaf1a598
Autor:
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, Fumitoshi Kodaka, Hiroyuki Muraoka, Kayo Ichihashi, Shinichiro Ochi, Shusuke Numata, Takashi Tsuboi, Manabu Makinodan, Hitoshi Iida, Toshiaki Onitsuka, Hiroko Kashiwagi, Masahiro Takeshima, Naoki Hashimoto, Tatsuya Nagasawa, Masahide Usami, Hirotaka Yamagata, Yoshikazu Takaesu, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Hisashi Yamada, Hikaru Hori, Ken Inada, Koichiro Watanabe, Ryota Hashimoto, Norio Yasui-Furukori
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background To examine whether the "Effectiveness of Guideline for Dissemination and Education in psychiatric treatment (EGIUDE)" project affects the rate of prescriptions of hypnotic medication and the type of hypnotic medications prescribed
Externí odkaz:
https://doaj.org/article/0cf33732107b44a0b14f4a60f84e72ac
Autor:
Ryuichi Yamazaki, Junya Matsumoto, Satsuki Ito, Kiyotaka Nemoto, Masaki Fukunaga, Naoki Hashimoto, Fumitoshi Kodaka, Harumasa Takano, Naomi Hasegawa, Yuka Yasuda, Michiko Fujimoto, Hidenaga Yamamori, Yoshiyuki Watanabe, Kenichiro Miura, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 206-215 (2024)
Abstract Establishing a brain biomarker for schizophrenia is strongly desirable not only to support diagnosis by psychiatrists but also to help track the progressive changes in the brain over the course of the illness. A brain morphological signature
Externí odkaz:
https://doaj.org/article/f63d409e9c7f4e6e822e230c480c1440
Autor:
Kentaro Morita, Kenichiro Miura, Atsuhito Toyomaki, Manabu Makinodan, Kazutaka Ohi, Naoki Hashimoto, Yuka Yasuda, Takako Mitsudo, Fumihiro Higuchi, Shusuke Numata, Akiko Yamada, Yohei Aoki, Hiromitsu Honda, Ryo Mizui, Masato Honda, Daisuke Fujikane, Junya Matsumoto, Naomi Hasegawa, Satsuki Ito, Hisashi Akiyama, Toshiaki Onitsuka, Yoshihiro Satomura, Kiyoto Kasai, Ryota Hashimoto
Publikováno v:
JMIR Mental Health, Vol 11, p e56668 (2024)
BackgroundSchizophrenia is a complex mental disorder characterized by significant cognitive and neurobiological alterations. Impairments in cognitive function and eye movement have been known to be promising biomarkers for schizophrenia. However, cog
Externí odkaz:
https://doaj.org/article/320b7793cec64719bb12220886cb4909
Autor:
Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima, Ken Inada
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 3, Pp 391-402 (2023)
Abstract Aim Continued antipsychotic treatment is the key to preventing relapse. Maintenance antipsychotic monotherapy and optimal dose use are recommended for individuals with stable schizophrenia because of their undesirable effects. Decision aids
Externí odkaz:
https://doaj.org/article/65c46ae618c340c9b815c5537485960b
Autor:
Naoki Hashimoto, Kohsuke Mori, Shuichiro Matsuzaki, Kazuki Iwama, Ryota Kitaura, Naoto Kamiuchi, Hideto Yoshida, Hiromi Yamashita
Publikováno v:
JACS Au, Vol 3, Iss 8, Pp 2131-2143 (2023)
Externí odkaz:
https://doaj.org/article/ef0de878e3f24440b88049086eeec2f0
Autor:
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Jun-ichi Iga, Kazuyoshi Ogasawara, Naoki Hashimoto, Hitoshi Iida, Kazutaka Ohi, Takashi Tsuboi, Shusuke Numata, Akitoyo Hishimoto, Masahide Usami, Eiichi Katsumoto, Hiroyuki Muraoka, Yoshikazu Takaesu, Tatsuya Nagasawa, Hiroshi Komatsu, Kenichiro Miura, Junya Matsumoto, Ken Inada, Shin Nakagawa, Ryota Hashimoto
Publikováno v:
Psychiatry Research Communications, Vol 4, Iss 1, Pp 100158- (2024)
Reports on polypharmacy strategies for patients with schizophrenia and major depressive disorder (MDD) are scarce. The nationwide Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project has been used to t
Externí odkaz:
https://doaj.org/article/45217934166b4aa3b62e84829ebe2f03
Autor:
Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, Shuhei Ishikawa, Hikaru Hori, Hitoshi Iida, Kayo Ichihashi, Kenichiro Miura, Junya Matsumoto, Shusuke Numata, Fumitoshi Kodaka, Ryuji Furihata, Kazutaka Ohi, Kazuyoshi Ogasawara, Jun-ichi Iga, Hiroyuki Muraoka, Hiroshi Komatsu, Masahiro Takeshima, Kiyokazu Atake, Mikio Kido, Toshinori Nakamura, Taishiro Kishimoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Tsuyoshi Okada, Shinichiro Ochi, Tatsuya Nagasawa, Manabu Makinodan, Hiroki Yamada, Takashi Tsuboi, Hisashi Yamada, Ken Inada, Koichiro Watanabe, Ryota Hashimoto
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Polypharmacy of additional psychotropics alongside the main treatment drug (antipsychotics in schizophrenia and antidepressants in major depressive disorder) is common in Japan. Our goal is to align psychotropic prescription in Ja
Externí odkaz:
https://doaj.org/article/79ad60b8b7d34dc8aaf4cc4645036c95
Autor:
Takashi Ozaki, Koichiro Mikami, Atsuhito Toyomaki, Naoki Hashimoto, Yoichi M. Ito, Ichiro Kusumi
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 2, Pp 177-187 (2023)
Abstract Aim Schizophrenia is characterized by an abnormality in electroencephalography (EEG), which can be affected by antipsychotic drugs. Recently, the mechanism underlying these EEG alterations in schizophrenia patients was reframed from the pers
Externí odkaz:
https://doaj.org/article/7a028dc7381a46bca4e3121f42828417
Autor:
Kentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, Hiroyuki Muraoka, Hikaru Hori, Kayo Ichihashi, Yuka Yasuda, Hitoshi Iida, Kazutaka Ohi, Shinichiro Ochi, Kenta Ide, Naoki Hashimoto, Masahide Usami, Toshinori Nakamura, Hiroshi Komatsu, Tsuyoshi Okada, Tatsuya Nagasawa, Ryuji Furihata, Kiyokazu Atake, Mikio Kido, Saya Kikuchi, Hirotaka Yamagata, Taishiro Kishimoto, Manabu Makinodan, Tadasu Horai, Masahiro Takeshima, Chika Kubota, Takeshi Asami, Eiichi Katsumoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Norio Yasui‐Furukori, Koichiro Watanabe, Ken Inada, Kotaro Otsuka, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 1, Pp 33-39 (2023)
Abstract Aim Treatment guidelines are designed to assist patients and health care providers and are used as tools for making treatment decisions in clinical situations. The treatment guidelines of the Japanese Society of Mood Disorders establish trea
Externí odkaz:
https://doaj.org/article/77c5010860b649c9b9cab36a727c3c74